Availability and provision of misoprostol and other medicines for menstrual regulation among pharmacies in Bangladesh via mystery client survey

Int J Gynaecol Obstet. 2014 Feb;124(2):164-8. doi: 10.1016/j.ijgo.2013.07.037. Epub 2013 Oct 31.

Abstract

Objective: To explore the availability and provision of misoprostol and other medicines for menstrual regulation (MR) among pharmacies in Bangladesh.

Methods: Between March and November 2011, a cross-sectional study using mystery client visits was conducted among pharmacy workers in Dhaka and Gazipur Districts, Bangladesh. Mystery clients were trained to present 1 of 4 pre-developed situations to pharmacy workers to elicit information on the regimen, adverse effects, and complications of misoprostol use.

Results: Mystery clients visited 331 pharmacies. Among the 331 pharmacy workers, 45.8% offered the mystery clients misoprostol and/or other medicines for MR; 25.7% referred them to private clinics or hospitals. Only 7% recommended an effective regimen of misoprostol for MR; 65% suggested administering vaginal and oral misoprostol together. Overall, 72.4% did not provide any advice on complications; the remainder suggested visiting trained providers for complications. Counseling on excessive bleeding as a danger sign was provided by 46% of pharmacy workers. Most (94%) did not provide or refer for post-MR family planning.

Conclusion: Pharmacy workers in urban Bangladesh are providing ineffective drugs and regimens for MR. A training package is needed to strengthen service delivery by providing accurate information, high-quality products, and referral mechanisms for women seeking MR through pharmacies.

Keywords: Abortion; Bangladesh; Menstrual regulation; Misoprostol; Pharmacy workers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortifacient Agents, Nonsteroidal* / adverse effects
  • Abortion, Induced
  • Adult
  • Bangladesh
  • Cross-Sectional Studies
  • Female
  • Health Services Accessibility / statistics & numerical data*
  • Humans
  • Male
  • Misoprostol*
  • Pharmacies / statistics & numerical data*
  • Young Adult

Substances

  • Abortifacient Agents, Nonsteroidal
  • Misoprostol